Subject: AWD
BD Named One of America's Most Innovative Companies by Fortune
FRANKLIN LAKES, N.J., March 31, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's 2025 list of America's Most Innovative Companies, ranking in the top 25% of companies overall. The list recognizes organizations that excel in developing innovative products, streamlining processes, and cultivating a forward-thinking corporate culture.
"As one of the largest manufacturers of medical devices in the world whose products touch billions of patients around the globe, building on our long history of innovation is a responsibility we take very seriously," said Tom Polen, chairman, CEO and president of BD. "Through the ingenuity of our world-class team who strives to address unmet needs in healthcare every day, coupled with BD Excellence - our culture of continuous improvement - we can live our purpose and manufacture innovative medical products at scale as we deliver for our customers and the patients we serve."
Fortune and Statista surveyed more than 40,000 U.S. employees and more than 2,500 industry experts to rank companies across the following three categories:
- Product innovation: Regular introduction of new products or services and improvement of existing products and services, in addition to the number and relevance of industrial property rights in the form of patents.
- Process innovation: Development and use of new and innovative technologies and production processes, as well as the innovative use of digitalization and the resulting opportunities.
- Innovation culture: Extent a company fosters a spirit of entrepreneurship and creativity, encouraging their employees to take initiative and develop new ideas.
For a full list of awards and recognitions BD has received, visit news.bd.com/Award-news.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Media:
Jessica Offerjost
BD Public Relations
201-258-0964
[email protected]
Investors:
Adam Reiffe
Sr. Director, Investor Relations
201-847-6927
[email protected]
SOURCE BD (Becton, Dickinson and Company)
These press releases may also interest you
|
News published on and distributed by:
